Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma
Status:
Unknown status
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and the toxicity of lobaplatin,
5-fluorouracil (5-FU) and leucovorin in patients with esophageal carcinoma.